Staphylokokkenbesiedelung im Kindesalter – Dynamik und Risikofaktoren

Kirsten Flügge; Reinhard Berner

doi:10.1055/s-0038-1628952

Kinder- und Jugendmedizin, Table of Contents

Kinder- und Jugendmedizin 2008; 08(02): 83-87
DOI: 10.1055/s-0038-1628952

Infektiologie

Schattauer GmbH

Staphylokokkenbesiedelung im Kindesalter – Dynamik und Risikofaktoren

Staphylococcus aureus colonization in childhood –dynamics and risk factors

Authors

Kirsten Flügge

¹Zentrum für Kinder- und Jugendmedizin des Universitätsklinikums Freiburg (Ärztlicher Direktor: Prof. Dr. med. Andrea Superti-Furga)
Reinhard Berner

¹Zentrum für Kinder- und Jugendmedizin des Universitätsklinikums Freiburg (Ärztlicher Direktor: Prof. Dr. med. Andrea Superti-Furga)

Abstract

Zusammenfassung

Staphylococcus aureus ist ein fakultativ pathogener Keim, der vornehmlich in der vorderen Nasenhöhle zu finden ist. 20–40% der gesunden Kinder sind mit S. aureus besiedelt, Methicillin-resistente S. aureus (MRSA)-Trägerraten in Deutschland sind bisher noch gering. Kolonisierungsraten variieren in verschiedenen Altersgruppen. Steigende S. aureus- und MRSA-Trägerraten lassen einen Anstieg der S. aureus-Infektionen auch bei Kindern erwarten. Daher ist eine genaue Kenntnis der regionalen und nationalen Träger- und Resistenzraten für die Therapie von S. aureus-Infektionen unerlässlich.

Summary

Staphylococcus aureus is an important pathogen. The anterior nares are their primary reservoir. 20–40% of healthy children are colonized with S. aureus, Methicillin-resistant Staphylococcus aureus (MRSA) carriage rates still remained low. Carriage rates differ between different age groups. Increasing carriage rates of S. aureus and MRSA could be an indicator of increasing staphylococcal infections in children. Therefore a precise knowledge of regional and national carriage and resistance rates are of major importance for the therapy of S. aureus infections.

Schlüsselwörter

Staphylococcus aureus - MRSA - Kolonisierung

Keywords

Staphylococcus aureus - MRSA - colonization

Full Text

References

Literatur
1 Adcock PM, Pastor P, Medley F. et al. Methicillinresistant Staphylococcus aureus in two child care centers. J Infect Dis 1998; 78 (02) 577-580.
2 Bogaert D, van Belkum A, Sluijter M. et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004; 363 9424 1871-1872.
3 Boubaker K, Diebold P, Blanc DS. et al. Pantonvalentine leukocidin and staphyloccoccal skin infections in schoolchildren. Emerg Infect Dis 2004; 10 (01) 121-124.
4 CDC.. Four pediatric deaths from communityacquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakot, 1997–1999. MMWR Morb Mort Wkly Rep 1999; 48: 707-710.
5 Cho SH, Strickland I, Tomkinson A. et al. Preferential Binding of Staphylococcus aureus to Skin Sites of Th2-Mediated Inflammation in a Murine Model. Journal of Investigative Dermatology 2001; 116: 658-663.
6 Creech 2nd CB, Kernodle DS, Alsentzer A. et al. Increasing rates of nasal carriage of methicillinresistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005; 24 (07) 617-621.
7 Diekema DJ, Pfaller MA, Schmitz FJ. et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 2001; 32 (02) S114-S1132.
8 Fluegge K, Adams B, Luetke Volksbeck U. et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in a southwestern region of Germany. Eur J Pediatr 2006; 165 (10) 688-690.
9 Gillet Y, Issartel B, Vanhems P. et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002; 359 9308 753-759.
10 Herold BC, Immergluck LC, Maranan MC. et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279 (08) 593-598.
11 Hörnig-Franz I, Kahl BC, Tebbe W. et al. Nekrotisierende Pneumonie mit Staphylococcus aureus (pvl-Gen positiv). Letal verlaufende Pneumonie bei einem 12-jährigen immunkompetenten Mädchen. Monatsschr Kinderheilk 2007; 155 (01) S10-S15.
12 Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J 2001; 20 (08) 763-767.
13 Jones ME, Karlowsky JA, Draghi DC. et al. Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients. Eur J Clin Microbiol Infect Dis 2004; 23 (06) 445-455.
14 Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10 (03) 505-520.
15 Kresken M, Hafner D, Schmitz F-J, Wichelhaus TA. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2004. Rheinbach: Antiinfectives Intelligence; 2006
16 Lina G, Piemont Y, Godail-Gamot F. et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29 (05) 1128-1132.
17 Lo WT, Lin WJ, Tseng MH. et al. Nasal carriage of a single clone of community-acquired methicillinresistant Staphylococcus aureus among kindergarten attendees in northern Taiwan. BMC Infect Dis 2007; 7: 51.
18 Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339 (08) 520-532.
19 Mainous 3rd AG, Hueston WJ, Everett CJ, Diaz VA. Nasal carriage of Staphylococcus aureus and methicillin-resistant S aureus in the United States, 2001–2002. Ann Fam Med 2006; 4 (02) 132-137.
20 Matsui K, Nishikawa A, Suto H. et al. Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis patients. Microbiol Immunol. 2000; 44 (11) 945-947.
21 Melles DC, Bogaert D, Gorkink RF. et al. Nasopharyngeal co-colonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. Microbiology 2007; 153 Pt 3 686-692.
22 Nakamura MM, Rohling KL, Shashaty M. et al. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J 2002; 21 (10) 917-922.
23 Osterlund A, Kahlmeter G, Bieber L. et al. Intrafamilial spread of highly virulent Staphylococcus aureus strains carrying the gene for Panton-Valentine Leukocidin. Scand J Infect Dis 2002; 34 (10) 763-764.
24 Peacock SJ, Justice A, Griffiths D. et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003; 41 (12) 5718-5725.
25 RKI.. Erkrankung durch Staphylococcus aureus unter besonderer Berücksichtigung der MRSA. Epid Bull. 8/00: 61-65.
26 Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2004; 4 (05) 373-378.
27 Sanford MD, Widmer AF, Bale MJ. et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus . Clin Infect Dis 1994; 19 (06) 1123-1128.
28 Veenhoven R, Bogaert D, Uiterwaal C. et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003; 361 9376 2189-2195.
29 Witte W, Kresken M, Braulke C, Cuny C. Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals. Clin Microbiol Infect 1997; 3 (04) 414-422.
30 Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5 (05) 275-286.